ANI PHARMACEUTICALS, INC Income Taxes Paid
ANI PHARMACEUTICALS, INC (ANIP) reported Income Taxes Paid of $17.67 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-02-27
- ANI PHARMACEUTICALS, INC income taxes paid for the quarter ending 2025-12-31 was $1.06M, a 42.56% decline year-over-year.
- ANI PHARMACEUTICALS, INC income taxes paid for the quarter ending 2025-09-30 was $140.00K, a 1300.00% increase year-over-year.
- ANI PHARMACEUTICALS, INC income taxes paid for the quarter ending 2025-06-30 was $16.19M, a 1.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC income taxes paid for the quarter ending 2025-03-31 was $285.00K, a 66.55% decline year-over-year.
- ANI PHARMACEUTICALS, INC income taxes paid for fiscal 2025 was $17.67M, a 7.28% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC income taxes paid for fiscal 2024 was $19.06M, a 1452.20% increase from fiscal 2023.
- ANI PHARMACEUTICALS, INC income taxes paid for fiscal 2023 was $1.23M, a 326.39% increase from fiscal 2022.
- ANI PHARMACEUTICALS, INC income taxes paid for fiscal 2022 was $288.00K, a 97.22% decline from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.20M derived: sum of 2 quarters · filed 2026-02-27 | $17.39M derived: sum of 3 quarters · filed 2026-02-27 | $17.67M 10-K · filed 2026-02-27 |
| 2025-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $16.33M derived: sum of 2 quarters · filed 2025-11-07 | $16.61M 10-Q · filed 2025-11-07 | $18.46M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $16.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $16.47M 10-Q · filed 2025-08-08 | $18.32M derived: sum of 3 quarters · filed 2026-02-27 | $18.33M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $285.00K 10-Q · filed 2025-05-09 | $2.13M derived: sum of 2 quarters · filed 2026-02-27 | $2.14M derived: sum of 3 quarters · filed 2026-02-27 | $18.49M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.86M derived: sum of 2 quarters · filed 2026-02-27 | $18.21M derived: sum of 3 quarters · filed 2026-02-27 | $19.06M 10-K · filed 2026-02-27 |
| 2024-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $16.36M derived: sum of 2 quarters · filed 2025-11-07 | $17.21M 10-Q · filed 2025-11-07 | $17.51M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $16.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $17.20M 10-Q · filed 2025-08-08 | $17.50M derived: sum of 3 quarters · filed 2026-02-27 | $18.29M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $852.00K 10-Q · filed 2025-05-09 | $1.15M derived: sum of 2 quarters · filed 2026-02-27 | $1.94M derived: sum of 3 quarters · filed 2026-02-27 | -$661.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.09M derived: sum of 2 quarters · filed 2026-02-27 | -$1.51M derived: sum of 3 quarters · filed 2026-02-27 | $1.23M 10-K · filed 2026-02-27 |
| 2023-09-30 | $789.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.81M derived: sum of 2 quarters · filed 2024-11-08 | $930.00K 10-Q · filed 2024-11-08 | $1.06M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $141.00K 10-Q · filed 2024-08-06 | $273.00K derived: sum of 3 quarters · filed 2025-02-28 | $305.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.74M 10-Q · filed 2024-05-10 | $2.87M derived: sum of 2 quarters · filed 2025-02-28 | $2.90M derived: sum of 3 quarters · filed 2025-02-28 | $3.03M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $164.00K derived: sum of 2 quarters · filed 2025-02-28 | $288.00K derived: sum of 3 quarters · filed 2025-02-28 | $288.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $156.00K derived: sum of 2 quarters · filed 2023-11-08 | $156.00K 10-Q · filed 2023-11-08 | $2.17M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $124.00K 10-Q · filed 2023-08-09 | $2.13M derived: sum of 3 quarters · filed 2024-02-29 | $2.13M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | $2.01M derived: sum of 2 quarters · filed 2024-02-29 | $2.01M derived: sum of 3 quarters · filed 2024-02-29 | $10.26M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.01M derived: sum of 2 quarters · filed 2024-02-29 | $10.26M derived: sum of 3 quarters · filed 2024-02-29 | $10.37M 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $8.25M derived: sum of 2 quarters · filed 2022-11-09 | $8.36M 10-Q · filed 2022-11-09 | $8.47M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | $8.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $8.36M 10-Q · filed 2022-08-08 | $8.47M derived: sum of 3 quarters · filed 2023-03-09 | $12.82M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-10 | $218.00K derived: sum of 2 quarters · filed 2023-03-09 | $4.57M derived: sum of 3 quarters · filed 2023-03-09 | $5.00M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.46M derived: sum of 2 quarters · filed 2023-03-09 | $4.89M derived: sum of 3 quarters · filed 2023-03-09 | $4.98M 10-K · filed 2023-03-09 |
| 2020-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $4.78M derived: sum of 2 quarters · filed 2021-11-01 | $4.88M 10-Q · filed 2021-11-01 | $5.02M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $523.00K 10-Q · filed 2021-08-06 | $663.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.83M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $95.00K 10-Q · filed 2021-05-07 | $235.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.41M derived: sum of 3 quarters · filed 2022-03-15 | $10.13M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.31M derived: sum of 2 quarters · filed 2022-03-15 | $10.03M derived: sum of 3 quarters · filed 2022-03-15 | $10.03M 10-K · filed 2022-03-15 |
| 2019-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.89M derived: sum of 2 quarters · filed 2020-11-05 | $9.89M 10-Q · filed 2020-11-05 | $12.40M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $8.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $8.72M 10-Q · filed 2020-08-06 | $11.23M derived: sum of 3 quarters · filed 2021-03-11 | $12.22M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $2.51M derived: sum of 2 quarters · filed 2021-03-11 | $3.50M derived: sum of 3 quarters · filed 2021-03-11 | $6.40M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.50M derived: sum of 2 quarters · filed 2021-03-11 | $6.40M derived: sum of 3 quarters · filed 2021-03-11 | $6.40M 10-K · filed 2021-03-11 |
| 2018-09-30 | $995.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $3.89M derived: sum of 2 quarters · filed 2019-11-06 | $3.89M 10-Q · filed 2019-11-06 | $9.18M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.90M 10-Q · filed 2019-08-07 | $8.19M derived: sum of 3 quarters · filed 2020-02-27 | $10.80M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | $5.29M derived: sum of 2 quarters · filed 2020-02-27 | $7.90M derived: sum of 3 quarters · filed 2020-02-27 | $17.78M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.90M derived: sum of 2 quarters · filed 2020-02-27 | $17.78M derived: sum of 3 quarters · filed 2020-02-27 | $17.79M 10-K · filed 2020-02-27 |
| 2017-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $12.49M derived: sum of 2 quarters · filed 2018-11-06 | $12.49M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $9.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $9.88M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $4.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $9.54M 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $13.26M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |